WAT

Waters Corporation (NYSE: WAT) introduced the Waters Xevo MRT P10 Mass Spectrometer, a high-resolution...

Published: Jun 1, 2026   |  Read Original Article ↗

Article Summary

BUY
  • Waters Corporation (NYSE: WAT) introduced the Waters Xevo MRT P10 Mass Spectrometer, a high-resolution Quadrupole Time-of-Flight System for high-throughput multiomics, bioanalysis, and biopharmaceutical laboratories, delivering up to 20x higher MS/MS sensitivity compared to its predecessor, industry-leading speed and expanded acquisition modes to comprehensively support both targeted and untargeted analysis in a single benchtop platform.
  • The system is designed to accelerate biomarker discovery and validation while supporting identification of disease pathways and therapeutic targets across large-cohort biomedical research and epidemiology studies, with acquisition speeds twice as fast as its predecessor making it the fastest benchtop HRMS system currently available.
  • When combined with DESI XS ion source, rapid spatial analysis is unlocked down to cellular level at up to 200 Hz increasing throughput six-fold while preserving image quality, with the new system supporting rapid throughput alongside exceptional resolution and mass accuracy delivering highest data quality and confidence.
Free users see 3 BUY signals per day. Premium unlocks all of them, plus instant email alerts. See Plans
Growth Stock Metric Rating
WAT Rating
49.5
SELL

Growth Stock Scoring Breakdown

METRIC VALUE WEIGHT ANALYSIS
Sales Growth TTM ? 26.4% 25% 75.0 ptsVery Good (26.4%) - Solid growth
EPS Growth Next 5Y ? 11.5% 25% 35.0 ptsBelow Screener (11.5%) - Modest outlook
Target Price Upside ? 6.2% 20% 35.0 ptsBelow Screener (6.2%) - Target: $402.74 vs Current: $379.35
Gross Margin % ? 50.2% 15% 80.0 ptsVery Healthy (50.2%) - High-quality margins
Drawdown from 52-Wk High ? -8.4% 15% 20.0 ptsBarely a Dip (-8.4%) - Near recent highs
Disclaimer: This rating is for informational purposes only and is not financial advice. All data sourced from Finviz. Always conduct your own research and consult with a financial advisor before making investment decisions. Past performance does not guarantee future results.

WAT - Daily Chart

Loading chart data...
Powered by Finviz & ApexCharts

About WAT

Healthcare Diagnostics & Research 16,000 employees Milford, MA, United States
  • Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe.
  • The company operates through two segments, Waters and TA.
  • The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products.
  • It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments.
  • In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing.
  • Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications.
  • The company was founded in 1958 and is headquartered in Milford, Massachusetts.
Get BUY-rated growth stocks delivered after market close.